MarketScreener Homepage > Equities > NASDAQ OMX STOCKHOLM > Biovica International AB (publ) BIOVIC B SE0008613731

Report

End-of-day quote NASDAQ OMX STOCKHOLM - 01/25
43.7	SEK		-2.89%

01/18

BIOVICA INTERNATIONAL : DiviTum®TKa in early treatment resistance trial

01/16

BIOVICA INTERNATIONAL : FDA resource reallocation continues to impact DiviTum®TKa timeline

01/12

BIOVICA INTERNATIONAL : CEO and main shareholder lends shares for redemption of option program

Upcoming events on BIOVICA INTERNATIONAL AB (PUBL)

- No events available -

Past events on BIOVICA INTERNATIONAL AB (PUBL)

- No events available -

Upcoming sector events for BIOVICA INTERNATIONAL AB (PUBL)

01/31/21		TURNING POINT THERAPEUTICS, INC. : Lung Cancer World Conference
02/01/21		VERTEX PHARMACEUTICALS INCORPORATED : FY 2020 Earnings Release
02/01/21 \| 04:30pm		VERTEX PHARMACEUTICALS INCORPORATED : FY 2020 Earnings Call
02/02/21 \| 09:00am		BIO-TECHNE CORPORATION : Interim 2021 Earnings Call

Past sector events for BIOVICA INTERNATIONAL AB (PUBL)

01/27/21 \| 08:30am		LONZA GROUP LTD : FY 2020 Earnings Call
01/27/21		GALAPAGOS NV : Degroof Petercam Healthcare Conference
01/27/21		LONZA GROUP LTD : FY 2020 Earnings Release
01/21/21 \| 10:30pm		BIOCON LIMITED : Q3 2021 Earnings Call

Annual publications

Annual results		2018	2019	2020	2021 (e)
Sales M SEK	Released Forecast Spread	9,95 8,60 16%	3,01 3,10 -3,1%	1,67 3,00 -44%	3,00
Operating income (EBITDA) M SEK	Released Forecast Spread	-15,2 -15,4 1,2%	-18,7 -16,0 -17%	-25,6 -32,2 20%	-36,0
Operating profit (EBIT) M SEK	Released Forecast Spread	-18,0 -18,7 4,0%	-21,7 -20,0 -8,6%	-29,8 -38,0 22%	-38,5
Pre-Tax Profit (EBT) M SEK	Released Forecast Spread	-18,0 -18,7 3,7%	-21,5 -19,0 -13%	-30,3 -37,7 20%	-38,5
Net income M SEK	Released Forecast Spread	-18,0 -18,7 3,7%	-21,6 -19,0 -13%	-30,3 -28,4 -6,8%	-38,5
EPS SEK	Released Forecast Spread	-1,02 -1,04 1,9%	-1,23 -1,10 -12%	-1,29 -1,60 19%	-1,40
Announcement Date		06/15/2018	06/14/2019	06/05/2020

Quarterly publications

Previous period

Next period

Quarterly results		2019 Q1	2019 Q2	2019 Q3	2019 Q4	2021 Q2	2021 Q3 (e)	2021 Q4 (e)	2022 Q1 (e)	2022 Q2 (e)	2022 Q3 (e)
Sales M SEK	Released Forecast Spread	2,28	0,07 1,00 -93%	0,29 1,00 -71%	1,72 1,00 72%		1,00	-2,00	7,00	12,0	17,0
Operating income (EBITDA) M SEK	Released Forecast Spread		-4,93 -4,00 -23%	-4,95 -4,00 -24%	-7,60 -4,00 -90%		-11,0	-14,0	-5,00	-7,00	-11,0
Operating profit (EBIT) M SEK	Released Forecast Spread		-5,61 -5,00 -12%	-5,78 -5,00 -16%	-8,57 -5,00 -71%		-11,0	-11,0	-5,00	-7,00	-11,0
Pre-Tax Profit (EBT) M SEK	Released Forecast Spread		-5,56 -5,00 -11%	-6,05 -5,00 -21%	-8,60 -5,00 -72%		-11,0	-11,0	-5,00	-7,00	-11,0
Net income M SEK	Released Forecast Spread		-5,56 -5,00 -11%	-6,05 -5,00 -21%	-8,63 -5,00 -73%	-8,21	-11,0	-11,0	-5,00	-7,00	-11,0
EPS SEK	Released Forecast Spread		-0,32 -0,26 -23%	-0,34 -0,28 -21%	-0,49 -0,26 -88%	-0,29	-0,39	-0,31	-0,14	-0,20	-0,32
Announcement Date		08/30/2018	12/06/2018	03/21/2019	06/14/2019	12/03/2020

Net sales (Year) - Rate of surprise

EPS (Year) - Rate of surprise

Net sales (Quarter) - Rate of surprise

EPS (Quarter) - Rate of surprise